Resultados de la búsqueda 231-240 of 996 for Alternative

1. Salud de los consumidores Fitness basics - Mayo Clinic

   Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Medicine. https://nccih.nih.gov ...

2. Oncología (médica) - Ensayos clínicos

   These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for these disorders. SULF1 ...

3. Oncología (médica) - Ensayos clínicos

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

4. Oncología (médica) - Ensayos clínicos

   The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

6. Oncología (médica) - Ensayos clínicos

   These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for these disorders. SULF1 ...

7. Salud de los consumidores Nutrition basics - Mayo Clinic

   Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Medicine. https://nccih.nih.gov ...

8. Oncología (médica) - Ensayos clínicos

   These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for these disorders. SULF1 ...

9. Oncología (médica) - Ensayos clínicos

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...